Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03165565 · ClinicalTrials.gov registry record · NA
Facilitating Treatment Entry and Family Planning in Substance-using Neonatal Intensive Care Unit (NICU) Mothers
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT03165565 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 64 participants.
The verdict
NCT03165565, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to assess whether the hospital-based, adaptive behavioral intervention strategy promotes treatment entry and reduces risk of additional substance-exposed pregnancies (SEPs), as well as HIV and Hepatitis C Virus (HCV) risks among substance-using NICU mothers. Additionally, to assess whether the intervention increases use of professional obstetrical/gynecological resources for contraception to reduce substance-exposed pregnancies (SEPs).
Interventions
- BEHAVIORAL Motivational Interviewing (MI) and Acceptance and Commitment Therapy (ACT)
- BEHAVIORAL Conventional Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2017-07-05 |
| Est. Completion | 2020-01-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03165565
The ClinicalTrials.gov registry entry for NCT03165565 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Motivational Interviewing (MI) and Acceptance and Commitment Therapy (ACT) is the first listed.
NCT03165565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03165565 about?
NCT03165565 is a clinical study titled "Facilitating Treatment Entry and Family Planning in Substance-using Neonatal Intensive Care Unit (NICU) Mothers". The purpose of this pilot study is to assess whether the hospital-based, adaptive behavioral intervention strategy promotes treatment entry and reduces risk of additional substance-exposed pregnancies (SEPs), as well as HIV and Hepatitis C Virus (HCV) risks among substance-using NICU mothers. Additi...
What is the current status of trial NCT03165565?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2017-07-05. Estimated completion is 2020-01-03.
What interventions are being tested in trial NCT03165565?
The interventions under investigation include: Motivational Interviewing (MI) and Acceptance and Commitment Therapy (ACT) (BEHAVIORAL), Conventional Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT03165565?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.